Table-V.
Variables | TACE+lenvatinib group (n=46) | TACE group (n=57) | χ2 | P |
---|---|---|---|---|
OS | ||||
1-year survival | 40 (86.96) | 41 (71.93) | 3.422 | 0.090 |
2-year survival | 34 (73.91) | 29 (50.88) | 5.687 | 0.025 |
PFS | ||||
1-year PFS | 35 (76.09) | 35 (61.40) | 2.521 | 0.139 |
2-year PFS | 23 (50.00) | 18 (31.58) | 3.605 | 0.070 |